ICUI
ICU Medical Inc is engaged in the development, manufacture and sale of medical devices used in infusion therapy, oncology and critical care applications. Its products include needlefree connectors, nanoclave, chemoclock, chemoclave, and among others.
ICU Medical, Inc. (ICUI) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B); its weakest is Growth (C-). The rating has held at C+ for 5 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-12 | C (2.4) | C- (2.0) | B- (3.1) | B (3.4) | C+ (2.6) | C+ (2.7) |
| 2026-11-05 | C- (1.9) | D+ (1.8) | B- (3.1) | B+ (3.5) | C+ (2.7) | C+ (2.6) |
| 2026-10-29 | C- (2.0) | D+ (1.7) | B- (3.1) | B (3.4) | C+ (2.7) | C+ (2.6) |
| 2026-10-22 | C- (2.0) | D+ (1.7) | B- (3.1) | B (3.3) | C+ (2.6) | C+ (2.6) |
| 2026-10-15 | C- (2.0) | D+ (1.8) | B- (3.1) | B- (3.1) | C+ (2.6) | C+ (2.5) |